Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Perfect Biotech International is a biotechnology firm specializing in regenerative medicine and advanced cellular therapies, primarily operating within the Asia-Pacific region. Closely affiliated with the Perfect (China) Group, the company focuses on the research and clinical application of stem cells and immune cells, including Natural Killer (NK) cells and Mesenchymal Stem Cells (MSCs). Their business model encompasses cell cryopreservation services, the development of wellness-oriented cell treatments, and the integration of biotechnology into health supplements. The company maintains specialized laboratories for cell expansion and quality control to support its clinical and anti-aging offerings. Perfect Biotech International aims to leverage cellular science to address chronic health conditions and promote longevity for its global clientele.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Perfect Biotech International.